Scientists hunt for blood clues to tame unpredictable swelling attacks

NCT ID NCT04963634

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to find biomarkers (measurable substances in the blood) that could help doctors diagnose bradykinin angioedema and predict how severe attacks might be. The condition causes sudden, unpredictable swelling, and current tests don't work well for all types. Researchers planned to compare blood proteins from patients with the condition to healthy people, but the study was stopped early after enrolling only one participant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACQUIRED BRADYKININ ANGIOEDEMA DUE TO C1 INHIBITOR DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hop Claude Huriez Chu Lille

    Lille, 59037, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.